Aquatic Animal Gene Editing

Customized aquatic animal gene editing solutions for gene function studies, disease model development, and trait improvement in fish, crustaceans, and mollusks.

Empowering Aquatic Research with Precision Gene Editing

Aquatic animal gene editing is an important tool for gene function studies, disease model development, and aquaculture innovation. However, successful projects often require more than editing reagents alone—they depend on species-adapted design, reliable embryo manipulation, accurate genotyping, and meaningful downstream validation. BioVenic provides customized solutions to support efficient and application-oriented genome editing in fish, crustaceans, and mollusks.

Ideal Projects We Support

  • Academic labs studying gene function and developmental biology.
  • Aquaculture teams evaluating traits like growth, disease resistance, and stress tolerance.
  • Biotech and pharma groups needing robust disease models or translational validation.
Gene editing with CRISPR/Cas9 nuclease. (Creative Biolabs Authorized)
Fig.1 Genome editing with CRISPR/Cas9 nuclease system in zebrafish (Danio rerio). 1,3

Common Challenges We Help Address

  • Variable editing efficiency across species
  • Limited workflows for non-model organisms
  • Long timelines for stable line generation
  • Gaps between genotype and downstream validation

To address these challenges, BioVenic offers flexible editing strategies and integrated downstream support tailored to diverse aquatic research needs.

Aquatic Genome Editing Services

Transgenesis

Applicable Scenarios:

Used to explore gene expression patterns, perform lineage tracing, or introduce commercially valuable traits such as enhanced disease resistance.

Technical Capabilities:

We leverage highly efficient Tol2 transposon systems and customized tissue-specific promoters to ensure robust integration and stable transgene or reporter expression.

Deliverables:

Microinjected embryos, confirmed F0 founders expressing the transgene, or established F1/F2 stable transgenic lines along with genotyping reports.

Gene Knockout

Applicable Scenarios:

Essential for loss-of-function studies, interrogating genetic pathways, and developing faithful models for human diseases or aquaculture traits.

Technical Capabilities:

Deploying advanced sequence-specific nuclease systems, we induce highly specific frameshift mutations while minimizing off-target effects through ribonucleoprotein (RNP) delivery.

Deliverables:

Sequence-verified mutant embryos, comprehensive high-resolution melt (HRM) screening data, identified F0 founders, and bi-allelic F1/F2 mutant lines.

Gene Knockdown

Applicable Scenarios:

Ideal for research requiring the transient suppression of gene expression, particularly during critical embryonic and larval developmental stages without permanent genomic alteration.

Technical Capabilities:

Targeting mRNA directly, our services employ precise antisense oligonucleotides (ASOs) and RNAi strategies to efficiently block translation or disrupt splicing.

Deliverables:

Microinjected knockdown embryos/larvae, tailored experimental protocols, and initial phenotypic evaluation documenting the transient loss-of-function.

Gene Knockin

Applicable Scenarios:

Required for introducing precise point mutations, fluorescent reporter tags, or replacing specific DNA sequence information one-to-one to mimic specific genetic variants.

Technical Capabilities:

We navigate Homology-Directed Repair (HDR) pathways using optimized programmable nuclease systems paired with ssODNs or plasmid donors to ensure targeted sequence integration.

Deliverables:

Custom donor design documentation, verified knockin embryos, rigorous off-target assessment data, and outcrossed F1 heterozygous stable lines.

Custom Inquiry Recommended

Streamlined Aquatic Animal Gene Editing Workflow

From target design to validated delivery, our workflow is built to improve project efficiency, reduce technical uncertainty, and support downstream analysis in aquatic models.

1

Strategy & Design

Consultation, sgRNA/donor design, and optimal nuclease selection tailored to the species.

2

Synthesis & Validation

in vitro synthesis of RNPs, MOs, or plasmids, followed by preliminary cleavage validation.

3

Microinjection

Precision injection into single-cell stage embryos and optimized husbandry of the F0 generation.

4

Genotyping

PCR, sequencing, and HRM analysis to verify mutations and assess mosaicism rates.

5

Delivery & Phenotyping

Breeding to stable F1/F2 lines, optional downstream multi-omics or phenotypic validation.

Why Choose BioVenic for Aquatic Genome Editing?

Species-Adapted Strategies

Tailored editing designs and husbandry for a diverse range of fish, crustaceans, and mollusks.

Flexible Editing Platforms

Support for transgenesis, knockout, knockdown, and knockin strategies across different project goals.

Integrated Validation

A continuous pipeline combining target design, genotyping, phenotypic tracking, and omics analysis.

Project-Oriented Delivery

We support both rapid F0 screening and the generation of stable, germline-transmitted models.

Applications of Aquatic Animal Gene Editing

Our precision models serve as powerful tools connecting upstream genotypes with downstream real-world applications across academia and industry.

Gene Function Analysis

Interrogate unknown gene pathways and physiological mechanisms.

Disease Model Generation

Replicate human genetic disorders or aquatic pathogenic susceptibilities.

Aquaculture Trait Improvement

Edit for enhanced growth rate, disease resistance, and environmental stress tolerance.

Translational Research

Validate candidate therapeutic drugs and nutritional targets using robust in vivo models.

Comparative Approaches to Aquatic Genome Modification

Approach Best For Editing Outcome Typical Use Case BioVenic Support
Advanced programmable nucleases Precise targeting, high efficiency Permanent (KO, KI, Point Mutation) Disease modeling, functional genomics, rapid F0 screening Custom guide design, RNP microinjection, F1/F2 breeding
Tol2 Transposon (or DNA transposon system) Large fragment integration Permanent (Random Integration) Stable transgenesis, fluorescent reporter lines, overexpression Vector construction, promoter optimization, founder identification
Antisense oligonucleotides (ASOs) Early developmental studies Transient Suppression (mRNA block) Embryonic pathway analysis, transient phenotype evaluation Custom ASO synthesis, titration, early stage microinjection
Customizable sequence-specific nucleases Complex or restricted genomic loci Permanent (KO) Editing targets with sequence constraints (e.g., restricted nuclease recognition sites) Custom nuclease assembly, off-target analysis

Published Data on Aquatic Gene Editing

Recent literature underscores the efficacy of alternative nucleases for refined genome engineering. For instance, a 2023 study in Transgenic Research demonstrated that a programmable nuclease with staggered DNA cleavage properties achieved potent in vivo knock-out efficiency at the slc45a2 locus in Atlantic salmon (Salmo salar L.).

Furthermore, such staggered cleavage patterns facilitate efficient homology-directed repair (HDR) for successful knock-in integrations. This highlights the expanding genome editing toolbox beyond conventional systems, enabling more versatile targeting in challenging aquatic models.

Building on these literature-backed advances, BioVenic designs project-specific editing strategies using appropriate nuclease systems, optimized donor formats, and robust validation workflows tailored specifically for diverse aquatic species.

slc45a2 knock-out by LbCas12a nuclease. (Creative Biolabs Authorized)
Fig.2 slc45a2 knock-out using LbCas12a nuclease. 2,3

Frequently Asked Questions

We support a wide array of aquatic species, heavily focusing on prominent models like zebrafish (Danio rerio), medaka, and Atlantic salmon (Salmo salar), as well as various commercially significant crustaceans and mollusks for aquaculture research. Our optimized microinjection and culture protocols are adapted to the specific developmental biology of each target species.

References

  1. Raudstein, Mari, et al. "in vivo CRISPR/LbCas12a-mediated knock-in and knock-out in Atlantic salmon (Salmo salar L.)." Transgenic Research 32.6 (2023): 513-521. https://doi.org/10.1007/s11248-023-00368-4
  2. Gutási, A., et al. "Review: Recent Applications of Gene Editing in Fish Species and Aquatic Medicine. Animals 2023, 13, 1250." 2023, https://doi.org/10.3390/ani13071250
  3. Distributed under Open Access license CC BY 4.0, without modification.
For research use only. Our products and services are for research use only and cannot be used for any clinical purposes.

Ready to Accelerate Your Research?

Get in touch with our aquatic genetics experts today. We provide free consultations and highly customized quotes to align seamlessly with your project goals, timelines, and budget.

Call Us Now:

Email Us:

Location:

Request a Quote

For research use only. Our products and services are for research use only and cannot be used for any clinical purposes.
Go To Top